SPATA1
gene geneOn this page
Also known as SP-2
Summary
SPATA1 (spermatogenesis associated 1, HGNC:14682) is a protein-coding gene on chromosome 1p22.3, encoding Spermatogenesis-associated protein 1 (Q5VX52).
Predicted to be located in acrosomal vesicle.
Source: NCBI Gene 100505741 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 3 total
- MANE Select transcript:
NM_001397487
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14682 |
| Approved symbol | SPATA1 |
| Name | spermatogenesis associated 1 |
| Location | 1p22.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SP-2 |
| Ensembl gene | ENSG00000122432 |
| Ensembl biotype | protein_coding |
| Entrez | 100505741 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 5 protein_coding_CDS_not_defined, 3 nonsense_mediated_decay, 1 retained_intron, 1 protein_coding
ENST00000460286, ENST00000468437, ENST00000473108, ENST00000484939, ENST00000485121, ENST00000490879, ENST00000697276, ENST00000697277, ENST00000699394, ENST00000699524
RefSeq mRNA: 2 — MANE Select: NM_001397487
NM_001310156, NM_001397487
CCDS: CCDS90993
Canonical transcript exons
ENST00000699524 — 14 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002170571 | 84506386 | 84506418 |
| ENSE00002448040 | 84525845 | 84526073 |
| ENSE00003537063 | 84516223 | 84516395 |
| ENSE00003810946 | 84525696 | 84525749 |
| ENSE00003976844 | 84545634 | 84545759 |
| ENSE00003976845 | 84555910 | 84555979 |
| ENSE00003976847 | 84532860 | 84532974 |
| ENSE00003976849 | 84565861 | 84567379 |
| ENSE00003976850 | 84520585 | 84520691 |
| ENSE00003976851 | 84548786 | 84548964 |
| ENSE00003976852 | 84544202 | 84544304 |
| ENSE00003976853 | 84522390 | 84522507 |
| ENSE00003976854 | 84533709 | 84533766 |
| ENSE00003976855 | 84550432 | 84550530 |
Expression profiles
Bgee: expression breadth ubiquitous, 176 present calls, max score 91.23.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1998 / max 11.4203, expressed in 68 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 3800 | 0.1998 | 68 |
Top tissues by expression
274 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 91.23 | silver quality |
| sperm | CL:0000019 | 89.65 | gold quality |
| male germ cell | CL:0000015 | 86.26 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.49 | gold quality |
| left testis | UBERON:0004533 | 79.05 | gold quality |
| right testis | UBERON:0004534 | 78.37 | gold quality |
| testis | UBERON:0000473 | 77.56 | gold quality |
| monocyte | CL:0000576 | 77.20 | gold quality |
| mononuclear cell | CL:0000842 | 76.95 | gold quality |
| calcaneal tendon | UBERON:0003701 | 76.80 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 76.24 | gold quality |
| leukocyte | CL:0000738 | 76.03 | gold quality |
| granulocyte | CL:0000094 | 75.51 | gold quality |
| right lobe of liver | UBERON:0001114 | 75.51 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 75.18 | gold quality |
| apex of heart | UBERON:0002098 | 73.92 | gold quality |
| adenohypophysis | UBERON:0002196 | 73.74 | gold quality |
| spleen | UBERON:0002106 | 73.01 | gold quality |
| tendon | UBERON:0000043 | 72.45 | gold quality |
| metanephros cortex | UBERON:0010533 | 72.11 | gold quality |
| mucosa of stomach | UBERON:0001199 | 71.98 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 71.90 | gold quality |
| right lung | UBERON:0002167 | 71.38 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 71.36 | gold quality |
| body of uterus | UBERON:0009853 | 71.18 | gold quality |
| thoracic aorta | UBERON:0001515 | 70.98 | gold quality |
| right coronary artery | UBERON:0001625 | 70.97 | gold quality |
| ascending aorta | UBERON:0001496 | 70.95 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 70.77 | gold quality |
| transverse colon | UBERON:0001157 | 70.53 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.23 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | SPATA1 | ENSDARG00000094327 |
| mus_musculus | Spata1 | ENSMUSG00000028188 |
| rattus_norvegicus | Spata1 | ENSRNOG00000015678 |
Protein
Protein identifiers
Spermatogenesis-associated protein 1 — Q5VX52 (reviewed: Q5VX52)
Alternative names: Sperm-specific protein SP-2
All UniProt accessions (4): A0A8V8TNC2, A0A8V8TNU4, A0A8V8TPQ3, A0A8V8TQ46
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Interacts with IFT20.
Subcellular location. Cytoplasmic vesicle. Secretory vesicle. Acrosome.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5VX52-1 | 1 | yes |
| Q5VX52-2 | 2 | |
| Q5VX52-4 | 3 |
RefSeq proteins (2): NP_001297085, NP_001384416* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031478 | SPATA1_C | Domain |
| IPR039062 | SPAT1 | Family |
Pfam: PF15743
UniProt features (11 total): splice variant 3, sequence conflict 2, coiled-coil region 2, chain 1, region of interest 1, compositionally biased region 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5VX52-F1 | 69.58 | 0.45 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 58 (showing top):
GOCC_SECRETORY_GRANULE, TCCAGAT_MIR5165P, chr1p22, GOCC_SECRETORY_VESICLE, GOCC_ACROSOMAL_VESICLE, KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES, IL15_UP.V1_DN, IL2_UP.V1_DN, HHEX_TARGET_GENES, NAB2_TARGET_GENES, NKX2_3_TARGET_GENES, PAF1_TARGET_GENES, UBN1_TARGET_GENES, ZNF22_TARGET_GENES, ZNF274_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (2): acrosomal vesicle (GO:0001669), cytoplasmic vesicle (GO:0031410)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| secretory granule | 1 |
| cytoplasm | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
204 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPATA1 | SPATA6L | Q8N4H0 | 445 |
| SPATA1 | SPATA6 | Q9NWH7 | 396 |
| SPATA1 | SPEF1 | Q9Y4P9 | 370 |
| SPATA1 | CTBS | Q01459 | 367 |
| SPATA1 | SPATA20 | Q8TB22 | 357 |
| SPATA1 | SPATA17 | Q96L03 | 355 |
| SPATA1 | SPATA4 | Q8NEY3 | 348 |
| SPATA1 | GMCL1 | Q96IK5 | 338 |
| SPATA1 | SPATA7 | Q9P0W8 | 317 |
| SPATA1 | SPAG16 | Q8N0X2 | 305 |
| SPATA1 | SPATA22 | Q8NHS9 | 302 |
| SPATA1 | SRM | P19623 | 289 |
| SPATA1 | LCA5 | Q86VQ0 | 288 |
| SPATA1 | ETNPPL | Q8TBG4 | 272 |
| SPATA1 | GNG5 | P30670 | 270 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SPATA1 | PCK1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (33): SPATA1 (Two-hybrid), UBR4 (Affinity Capture-MS), SCYL2 (Affinity Capture-MS), TLK2 (Affinity Capture-MS), TLK1 (Affinity Capture-MS), MAP3K4 (Affinity Capture-MS), WNK2 (Affinity Capture-MS), SMG6 (Affinity Capture-MS), WNK1 (Affinity Capture-MS), LRRC49 (Affinity Capture-MS), VPS39 (Affinity Capture-MS), C2orf44 (Affinity Capture-MS), NECAP2 (Affinity Capture-MS), KDM5C (Affinity Capture-MS), CMTR1 (Affinity Capture-MS)
ESM2 similar proteins: A0A1W2P884, A2RUB6, A7E3D8, A8MT70, B0CM36, B2RYR0, F1PZQ5, O95447, Q0IIM1, Q0P5X1, Q2KHM9, Q2T9X8, Q4KLH6, Q4R3Q7, Q4R6Q9, Q5NVK0, Q5R7F8, Q5RBD6, Q5RBY6, Q5RC32, Q5RD75, Q5SZL2, Q5TB80, Q5TID7, Q5VX52, Q5XI03, Q6A000, Q6NS45, Q6NZK5, Q6ZPR1, Q6ZQ06, Q7Z4H7, Q80VP2, Q80XJ2, Q80ZU5, Q86T90, Q86YF9, Q8BMD2, Q8IYW5, Q8N0Z3
Diamond homologs: Q5VX52, Q6AY22, Q9D5R4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
3 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
554 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:84563243:A:AC | donor_gain | 1.0000 |
| 1:84563244:C:CC | donor_gain | 1.0000 |
| 1:84563255:A:AC | donor_gain | 1.0000 |
| 1:84563256:C:CC | donor_gain | 1.0000 |
| 1:84563414:TGATC:T | acceptor_gain | 1.0000 |
| 1:84563419:C:A | acceptor_loss | 1.0000 |
| 1:84563419:C:CC | acceptor_gain | 1.0000 |
| 1:84563420:T:A | acceptor_loss | 1.0000 |
| 1:84563729:TCCTA:T | donor_loss | 1.0000 |
| 1:84563731:CTACC:C | donor_loss | 1.0000 |
| 1:84563733:A:AT | donor_loss | 1.0000 |
| 1:84564206:A:C | donor_gain | 1.0000 |
| 1:84565835:TCTTA:T | donor_loss | 1.0000 |
| 1:84565836:CTTA:C | donor_loss | 1.0000 |
| 1:84565837:TTA:T | donor_loss | 1.0000 |
| 1:84565838:TA:T | donor_loss | 1.0000 |
| 1:84565839:A:AC | donor_gain | 1.0000 |
| 1:84565840:C:A | donor_loss | 1.0000 |
| 1:84565840:C:CC | donor_gain | 1.0000 |
| 1:84555030:T:TA | donor_gain | 0.9900 |
| 1:84555031:C:A | donor_gain | 0.9900 |
| 1:84563417:TC:T | acceptor_gain | 0.9900 |
| 1:84563418:CC:C | acceptor_gain | 0.9900 |
| 1:84565834:GTCTT:G | donor_loss | 0.9900 |
| 1:84565839:AC:A | donor_gain | 0.9900 |
| 1:84565840:CC:C | donor_gain | 0.9900 |
| 1:84565840:CCA:C | donor_gain | 0.9900 |
| 1:84565840:CCAG:C | donor_gain | 0.9900 |
| 1:84565884:TTCTG:T | donor_gain | 0.9900 |
| 1:84566009:TTACC:T | acceptor_gain | 0.9900 |
AlphaMissense
2860 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:84520610:T:A | V43D | 0.996 |
| 1:84520624:T:A | W48R | 0.996 |
| 1:84520624:T:C | W48R | 0.996 |
| 1:84520601:T:A | V40D | 0.995 |
| 1:84520626:G:C | W48C | 0.994 |
| 1:84520626:G:T | W48C | 0.994 |
| 1:84520684:T:C | F68L | 0.994 |
| 1:84520686:T:A | F68L | 0.994 |
| 1:84520686:T:G | F68L | 0.994 |
| 1:84525861:T:C | L133S | 0.994 |
| 1:84522476:T:C | F99S | 0.992 |
| 1:84522479:T:C | L100P | 0.992 |
| 1:84525735:T:C | F123L | 0.992 |
| 1:84525737:T:A | F123L | 0.992 |
| 1:84525737:T:G | F123L | 0.992 |
| 1:84525867:T:C | L135S | 0.992 |
| 1:84522469:T:C | F97L | 0.991 |
| 1:84522471:T:A | F97L | 0.991 |
| 1:84522471:T:G | F97L | 0.991 |
| 1:84525863:T:G | Y134D | 0.991 |
| 1:84522410:T:C | L77S | 0.990 |
| 1:84522419:T:C | L80P | 0.990 |
| 1:84522475:T:C | F99L | 0.990 |
| 1:84522477:T:A | F99L | 0.990 |
| 1:84522477:T:G | F99L | 0.990 |
| 1:84525721:T:C | L118P | 0.990 |
| 1:84520595:T:C | L38P | 0.989 |
| 1:84522500:T:C | L107S | 0.989 |
| 1:84520625:G:C | W48S | 0.988 |
| 1:84520669:T:C | F63L | 0.988 |
dbSNP variants (sampled 300 via entrez): RS1000019693 (1:84530081 C>T), RS1000087909 (1:84528671 T>A,C), RS1000090045 (1:84510811 C>T), RS1000130325 (1:84558552 A>G), RS1000185189 (1:84549896 C>A,T), RS1000222999 (1:84508936 G>C,T), RS1000251317 (1:84558259 C>G), RS1000278089 (1:84551503 A>C), RS1000289753 (1:84551792 T>C), RS1000296687 (1:84508591 T>G), RS1000300596 (1:84514606 G>A), RS1000307211 (1:84518046 T>C), RS1000396000 (1:84565154 G>A), RS1000441163 (1:84544897 A>C), RS1000497511 (1:84529796 T>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| hydroxyhydroquinone | increases expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| beta-lapachone | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| maleic acid | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Urethane | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
| S-Nitrosoglutathione | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.